Rossari Biotech

Market Cap: Small Cap
Industry: Specialty Chemicals
ISIN: INE02A801020
NSEID: ROSSARI
BSEID: 543213

INR

569.80

-0.65 (-0.11%)

BSENSE

Dec 19

BSE+NSE Vol: 56.64 k

{
  "main_header": {
    "sid": 1003405,
    "name": "Rossari Biotech",
    "stock_name": "Rossari Biotech",
    "full_name": "Rossari Biotech Ltd",
    "name_url": "stocks-analysis/rossari-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "569.80",
    "chg": -0.65,
    "chgp": "-0.11%",
    "dir": -1,
    "prev_price": "570.45",
    "mcapval": "3,182.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543213,
    "symbol": "ROSSARI",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE02A801020",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "56.64 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rossari-biotech-1003405-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Rossari Biotech Falls to 52-Week Low of Rs.563.65 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-falls-to-52-week-low-amidst-continued-underperformance-3762525",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RossariBiotech_priceRelatedfactors_3762525.png",
        "date": "2025-12-18 10:12:45",
        "description": "Rossari Biotech has reached a new 52-week low of Rs.563.65, marking a significant point in its recent trading performance as the stock continues to trade below all major moving averages amid a sustained period of decline."
      },
      {
        "title": "Rossari Biotech Falls to 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-stock-falls-to-52-week-low-amid-continued-underperformance-3761503",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RossariBiotech_priceRelatedfactors_3761503.png",
        "date": "2025-12-17 16:02:40",
        "description": "Rossari Biotech's stock has reached a fresh 52-week low, closing just 0.45% above its lowest price in the past year at Rs 566. The stock has been on a declining trajectory over the last three trading sessions, reflecting ongoing pressures within the specialty chemicals sector."
      },
      {
        "title": "Rossari Biotech Falls to 52-Week Low of Rs.566 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-stock-falls-to-52-week-low-of-rs566-amid-continued-downtrend-3753833",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RossariBiotech_priceRelatedfactors_3753833.png",
        "date": "2025-12-09 11:35:19",
        "description": "Rossari Biotech's stock price reached a fresh 52-week low of Rs.566 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures within the specialty chemicals segment."
      },
      {
        "title": "Rossari Biotech Faces Market Assessment Shift Amidst Technical and Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rossari-biotech-downgraded-to-sell-amid-weak-technicals-and-flat-financials-3753108",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RossariBiotech_mojoScore_3753108.png",
        "date": "2025-12-09 09:02:38",
        "description": "Rossari Biotech, a key player in the Specialty Chemicals sector, has experienced a notable shift in market evaluation following recent developments across technical indicators, financial trends, valuation metrics, and overall quality parameters. This article analyses the factors influencing the revised market perspective on the company amid a challenging performance backdrop."
      },
      {
        "title": "Rossari Biotech Technical Momentum Shifts Amid Bearish Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-technical-momentum-shifts-to-bearish-amid-market-uncertainty-3752918",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RossariBiotech_technicaldot_3752918.png",
        "date": "2025-12-09 08:19:18",
        "description": "Rossari Biotech, a key player in the Specialty Chemicals sector, is currently exhibiting a shift in its technical momentum, with multiple indicators signalling a bearish trend across weekly and monthly timeframes. This article analyses the recent changes in technical parameters including MACD, RSI, moving averages, and other momentum oscillators to provide a comprehensive view of the stock’s current market stance."
      },
      {
        "title": "Is Rossari Biotech technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-rossari-biotech-technically-bullish-or-bearish-3743184",
        "imagepath": "",
        "date": "2025-12-03 08:56:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Current Price Action and Trend</strong></p>\n<p>As of 2 December 2025, Rossari Biotech’s technical trend shifted from bearish to mildly bearish, signalling a tentative improvement but still reflecting underlying weakness. The stock closed at ₹606.00, marginally higher than the previous close of ₹601.30, with intraday trading ranging between ₹595.50 and ₹606.00. This price action indicates some buying interest near the lower end of its 52-week range, which spans from ₹568.05 to ₹883.00.</p>\n<p>Despite this modest uptick, the stock remains significantly below its 52-week high, underscoring the challenges it faces in regaining momentum. The current price level is closer to the lower band of its annual range, suggesting that investors remain cautious amid broader market uncertainties ..."
      },
      {
        "title": "Rossari Biotech: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rossari-biotech-upgraded-to-hold-as-technicals-improve-amidst-flat-financials-3743155",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RossariBiotech_mojoScore_3743155.png",
        "date": "2025-12-03 08:25:49",
        "description": "Rossari Biotech, a key player in the Specialty Chemicals sector, has experienced a revision in its market assessment following a detailed review of its financial performance, valuation metrics, technical indicators, and overall quality parameters. This article explores the factors influencing the recent changes in the company’s evaluation, providing investors with a comprehensive understanding of its current standing."
      },
      {
        "title": "Rossari Biotech Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-technical-momentum-shifts-amid-mixed-market-signals-3743000",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RossariBiotech_technicaldot_3743000.png",
        "date": "2025-12-03 08:08:46",
        "description": "Rossari Biotech, a key player in the specialty chemicals sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent data reveals a transition from a bearish technical trend to a mildly bearish stance, underscoring a period of consolidation and cautious investor sentiment."
      },
      {
        "title": "How has been the historical performance of Rossari Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-rossari-biotech-3742272",
        "imagepath": "",
        "date": "2025-12-02 23:04:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Rossari Biotech's net sales have shown a remarkable upward trend, rising from ₹600.09 crores in March 2020 to ₹2,080.29 crores by March 2025. This more than threefold increase over five years underscores the company's expanding market presence and product demand. Correspondingly, the total operating income mirrored this growth, reflecting the absence of other operating income during this period.</p>\n<p>Profitability metrics have also improved significantly. The consolidated net profit increased from ₹65.25 crores in March 2020 to ₹136.38 crores in March 2025, nearly doubling in size. Earnings per share (EPS) followed suit, climbing from ₹12.86 to ₹24.64, indicating enhanced returns for shareholders. Despite this growth, the profit after tax (PAT) mar..."
      }
    ],
    "total": 161,
    "sid": "1003405",
    "stock_news_url": "https://www.marketsmojo.com/news/rossari-biotech-1003405"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On December 18 2025.",
      "datetime": "18-Dec-2025",
      "details": "The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Republic of Singapore and other matters.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
      "datetime": "18-Dec-2025",
      "details": "Incorporation of Rossari (Singapore) Pte. Ltd. in Republic of Singapore wholly owned subsidiary of Rossari Biotech Limited.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "03-Dec-2025",
      "details": "Intimation of affirmation of Credit Rating.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Rossari Biotech Ltd has declared <strong>25%</strong> dividend, ex-date: 16 Aug 24",
          "dt": "2024-08-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Rossari Biotech Falls to 52-Week Low of Rs.563.65 Amidst Prolonged Downtrend

2025-12-18 10:12:45

Rossari Biotech has reached a new 52-week low of Rs.563.65, marking a significant point in its recent trading performance as the stock continues to trade below all major moving averages amid a sustained period of decline.

Rossari Biotech Falls to 52-Week Low Amid Continued Downtrend

2025-12-17 16:02:40

Rossari Biotech's stock has reached a fresh 52-week low, closing just 0.45% above its lowest price in the past year at Rs 566. The stock has been on a declining trajectory over the last three trading sessions, reflecting ongoing pressures within the specialty chemicals sector.

Rossari Biotech Falls to 52-Week Low of Rs.566 Amid Continued Downtrend

2025-12-09 11:35:19

Rossari Biotech's stock price reached a fresh 52-week low of Rs.566 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures within the specialty chemicals segment.

Rossari Biotech Faces Market Assessment Shift Amidst Technical and Financial Challenges

2025-12-09 09:02:38

Rossari Biotech, a key player in the Specialty Chemicals sector, has experienced a notable shift in market evaluation following recent developments across technical indicators, financial trends, valuation metrics, and overall quality parameters. This article analyses the factors influencing the revised market perspective on the company amid a challenging performance backdrop.

Rossari Biotech Technical Momentum Shifts Amid Bearish Indicators

2025-12-09 08:19:18

Rossari Biotech, a key player in the Specialty Chemicals sector, is currently exhibiting a shift in its technical momentum, with multiple indicators signalling a bearish trend across weekly and monthly timeframes. This article analyses the recent changes in technical parameters including MACD, RSI, moving averages, and other momentum oscillators to provide a comprehensive view of the stock’s current market stance.

Is Rossari Biotech technically bullish or bearish?

2025-12-03 08:56:04

Overview of Current Price Action and Trend

As of 2 December 2025, Rossari Biotech’s technical trend shifted from bearish to mildly bearish, signalling a tentative improvement but still reflecting underlying weakness. The stock closed at ₹606.00, marginally higher than the previous close of ₹601.30, with intraday trading ranging between ₹595.50 and ₹606.00. This price action indicates some buying interest near the lower end of its 52-week range, which spans from ₹568.05 to ₹883.00.

Despite this modest uptick, the stock remains significantly below its 52-week high, underscoring the challenges it faces in regaining momentum. The current price level is closer to the lower band of its annual range, suggesting that investors remain cautious amid broader market uncertainties ...

Rossari Biotech: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals

2025-12-03 08:25:49

Rossari Biotech, a key player in the Specialty Chemicals sector, has experienced a revision in its market assessment following a detailed review of its financial performance, valuation metrics, technical indicators, and overall quality parameters. This article explores the factors influencing the recent changes in the company’s evaluation, providing investors with a comprehensive understanding of its current standing.

Rossari Biotech Technical Momentum Shifts Amid Mixed Market Signals

2025-12-03 08:08:46

Rossari Biotech, a key player in the specialty chemicals sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent data reveals a transition from a bearish technical trend to a mildly bearish stance, underscoring a period of consolidation and cautious investor sentiment.

How has been the historical performance of Rossari Biotech?

2025-12-02 23:04:54

Revenue and Profit Growth

Rossari Biotech's net sales have shown a remarkable upward trend, rising from ₹600.09 crores in March 2020 to ₹2,080.29 crores by March 2025. This more than threefold increase over five years underscores the company's expanding market presence and product demand. Correspondingly, the total operating income mirrored this growth, reflecting the absence of other operating income during this period.

Profitability metrics have also improved significantly. The consolidated net profit increased from ₹65.25 crores in March 2020 to ₹136.38 crores in March 2025, nearly doubling in size. Earnings per share (EPS) followed suit, climbing from ₹12.86 to ₹24.64, indicating enhanced returns for shareholders. Despite this growth, the profit after tax (PAT) mar...

View All News